Opportunities and Barriers to Innovation in Acute Care Pediatrics

by Lakhmir S. Chawla
Published 2020-02-01

Renal Stress Testing in the Assessment of Kidney Disease

by Lakhmir S. Chawla, Claudio Ronco
Published 2016-05-01

The furosemide stress test: current use and future potential

by Blaithin A. McMahon, Lakhmir S. Chawla
Published 2021-01-01

Broad spectrum vasopressors: a new approach to the initial management of septic shock?

by Lakhmir S. Chawla, Marlies Ostermann, Lui Forni, George F. Tidmarsh
Published 2019-04-01

Angiotensin converting enzyme defects in shock: implications for future therapy

by Lakhmir S. Chawla, Steve Chen, Rinaldo Bellomo, George F. Tidmarsh
Published 2018-10-01

Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease

by Jesús Rivero, Francisco Rodríguez, Virgilia Soto, Etienne Macedo, Lakhmir S. Chawla, Ravindra L. Mehta, Sucheta Vaingankar, Pranav S. Garimella, Carlos Garza, Magdalena Madero
Published 2020-03-01

Demographic data for urinary Acute Kidney Injury (AKI) marker [IGFBP7]·[TIMP2] reference range determinations

by Nandkishor S. Chindarkar, Lakhmir S. Chawla, Joely A. Straseski, Saeed A. Jortani, Denise Uettwiller-Geiger, Robert R. Orr, John A. Kellum, Robert L. Fitzgerald
Published 2015-12-01

Utilizing Electronic Health Records to Predict Acute Kidney Injury Risk and Outcomes: Workgroup Statements from the 15 ADQI Consensus Conference

by Scott M. Sutherland, Lakhmir S. Chawla, Sandra L. Kane-Gill, Raymond K. Hsu, Andrew A. Kramer, Stuart L. Goldstein, John A. Kellum, Claudio Ronco, Sean M. Bagshaw
Published 2016-02-01

Safety and Tolerability Study of an Intravenously Administered Small Interfering Ribonucleic Acid (siRNA) Post On-Pump Cardiothoracic Surgery in Patients at Risk of Acute Kidney In...

by Segav Demirjian, Gorav Ailawadi, Martin Polinsky, Dani Bitran, Shuli Silberman, Stanton Keith Shernan, Michel Burnier, Marta Hamilton, Elizabeth Squiers, Shai Erlich, Daniel Rothenstein, Samina Khan, Lakhmir S. Chawla
Published 2017-09-01

External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury

by Sean M. Bagshaw, Ali Al-Khafaji, Antonio Artigas, Danielle Davison, Michael Haase, Matthew Lissauer, Kai Zacharowski, Lakhmir S. Chawla, Thomas Kwan, J. Patrick Kampf, Paul McPherson, John A. Kellum
Published 2021-05-01

Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial

by Kealy R. Ham, David W. Boldt, Michael T. McCurdy, Laurence W. Busse, Raphael Favory, Michelle N. Gong, Ashish K. Khanna, Stefan N. Chock, Feng Zeng, Lakhmir S. Chawla, George F. Tidmarsh, Marlies Ostermann
Published 2019-06-01

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock

by Rinaldo Bellomo, Richard G. Wunderink, Harold Szerlip, Shane W. English, Laurence W. Busse, Adam M. Deane, Ashish K. Khanna, Michael T. McCurdy, Marlies Ostermann, Paul J. Young, Damian R. Handisides, Lakhmir S. Chawla, George F. Tidmarsh, Timothy E. Albertson
Published 2020-02-01